Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L431483-100g | 100g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $314.90 | |
L431483-500g | 500g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,083.90 |
Synonyms | L-Arginine hydrochloride|1119-34-2|Arginine Hydrochloride|L-Arginine monohydrochloride|L-ARGININE HCL|H-Arg-OH.HCl|15595-35-4|Arginine HCl|Argamine|Argivene|Detoxargin|Levargin|Minophagen A|R-Gene|Arginine monohydrochloride|Tivortin|R-gene 10|L-(+)-Argini |
---|---|
Specifications & Purity | UltraBio™, Ultra pure, BioReagent, ≥99.5%(AT) |
Biochemical and Physiological Mechanisms | L-Arginine is considered as a semi essential amino acid. In most mammals including humans, L-Arginine synthesis occurs through intestinal-renal axis, from glutamine, glutamate and proline. Abnormal levels of L-Arginine is associated with the development o |
Grade | BioReagent, Ultra pure, UltraBio™ |
Product Description | Application L-Arginine monohydrochloride has been used to study the reversal of the inhibitory effect of L-N G 0-nitroarginine on non-cholinergic relaxations. It has also been used as a dietary supplement to study its effect on endothelium-dependent vasodilation. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid;hydrochloride |
---|---|
INCHI | InChI=1S/C6H14N4O2.ClH/c7-4(5(11)12)2-1-3-10-6(8)9;/h4H,1-3,7H2,(H,11,12)(H4,8,9,10);1H/t4-;/m0./s1 |
InChi Key | KWTQSFXGGICVPE-WCCKRBBISA-N |
Canonical SMILES | Cl[H].N[C@@H](CCCNC(N)=N)C(O)=O |
Isomeric SMILES | C(C[C@@H](C(=O)O)N)CN=C(N)N.Cl |
WGK Germany | 1 |
Alternate CAS | 15595-35-4 |
PubChem CID | 66250 |
Molecular Weight | 210.66 |
Beilstein | 6099937 |
Enter Lot Number to search for COA:
Solubility | H2O: 1M at20°C, clear, colorless |
---|---|
Specific Rotation[α] | 23 ° (C=8, HCl(1+1)) |
Melt Point(°C) | 226-230°C |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation |
Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P264:Wash hands [and …] thoroughly after handling. P362+P364:Take off contaminated clothing and wash it before reuse. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. |
WGK Germany | 1 |
Merck Index | 780 |
1. Rahul D Sheth,Mi Jin,Bharat V Bhut,Zhengjian Li,Wilfred Chen,Steven M Cramer. (2014-03-07) Affinity precipitation of a monoclonal antibody from an industrial harvest feedstock using an ELP-Z stimuli responsive biopolymer.. Biotechnology and bioengineering, 111 ((8)): (1595-1603). [PMID:24595842] |
2. Lucie Holubova,Lucie Korecka,Stepan Podzimek,Veronika Moravcova,Jana Rotkova,Tereza Ehlova,Vladimir Velebny,Zuzana Bilkova. (2014-08-19) Enhanced multiparametric hyaluronan degradation for production of molar-mass-defined fragments.. Carbohydrate polymers, 112 (271-276). [PMID:25129744] |
3. Nivaldo Ribeiro Villela,Ana Olimpia Maia Teixeira dos Santos,Marcos Lopes de Miranda,Eliete Bouskela. (2014-08-26) Fluid resuscitation therapy in endotoxemic hamsters improves survival and attenuates capillary perfusion deficits and inflammatory responses by a mechanism related to nitric oxide.. Journal of translational medicine, 12 (232-232). [PMID:25151363] |
4. Carolina Di Somma,Alessandro Ciresi,Marco C Amato,Silvia Savastano,Maria Cristina Savanelli,Elisabetta Scarano,Annamaria Colao,Carla Giordano. (2014-11-10) Alteration of the growth hormone axis, visceral fat dysfunction, and early cardiometabolic risk in adults: the role of the visceral adiposity index.. Endocrine, 49 ((2)): (492-502). [PMID:25381601] |
5. X Zheng,X Cheng,L Wang,W Qiu,S Wang,Y Zhou,M Li,Y Li,L Cheng,J Li,X Zhou,X Xu. (2014-12-06) Combinatorial effects of arginine and fluoride on oral bacteria.. Journal of dental research, 94 ((2)): (344-353). [PMID:25477312] |
6. Hao Zheng, Cui Tang, Chunhua Yin,. (2014-12-24) Exploring advantages/disadvantages and improvements in overcoming gene delivery barriers of amino acid modified trimethylated chitosan.. Pharmaceutical research, 32 ((6)): ( 2038-2050 ). [PMID:25534683] |
7. C B Christiansen,B Svendsen,J J Holst. (2015-01-21) The VGF-Derived Neuropeptide TLQP-21 Shows No Impact on Hormone Secretion in the Isolated Perfused Rat Pancreas.. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 47 ((7)): (537-543). [PMID:25602348] |
8. Renata V Tiradentes,Cintia H Santuzzi,Erick Rg Claudio,Vinicius Mengal,Nyam F Silva,Henrique A F Neto,Nazaré S Bissoli,Glaucia R Abreu,Sonia A Gouvea. (2015-03-06) Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model.. Hypertension research : official journal of the Japanese Society of Hypertension, 38 ((7)): (471-477). [PMID:25740291] |
9. Yumiko Mizukoshi,Koh Takeuchi,Misa Arutaki,Takeshi Takizawa,Hiroyuki Hanzawa,Hideo Takahashi,Ichio Shimada. (2015-03-12) Suppression of problematic compound oligomerization by cosolubilization of nondetergent sulfobetaines.. ChemMedChem, 10 ((4)): (736-741). [PMID:25760302] |
10. Jenna Gallie,Eric Libby,Frederic Bertels,Philippe Remigi,Christian B Jendresen,Gayle C Ferguson,Nicolas Desprat,Marieke F Buffing,Uwe Sauer,Hubertus J E Beaumont,Jan Martinussen,Mogens Kilstrup,Paul B Rainey. (2015-03-13) Bistability in a metabolic network underpins the de novo evolution of colony switching in Pseudomonas fluorescens.. PLoS biology, 13 ((3)): (e1002109-e1002109). [PMID:25763575] |
11. L Rascón-Valenzuela,C Velázquez,A Garibay-Escobar,L A Medina-Juárez,W Vilegas,R E Robles-Zepeda. (2015-06-13) Antiproliferative activity of cardenolide glycosides from Asclepias subulata.. Journal of ethnopharmacology, 171 (280-286). [PMID:26068432] |
12. Jun Yeul Lim,Nam Ah Kim,Dae Gon Lim,Ki Hyun Kim,Shavron Hada,Seong Hoon Jeong. (2015-07-19) Evaluation of etanercept degradation under oxidative stress and potential protective effects of various amino acids.. International journal of pharmaceutics, 492 ((1-2)): (127-136). [PMID:26187168] |
13. Caroline Nava,Johanna Rupp,Jean-Paul Boissel,Cyril Mignot,Agnès Rastetter,Claire Amiet,Aurélia Jacquette,Céline Dupuits,Delphine Bouteiller,Boris Keren,Merle Ruberg,Anne Faudet,Diane Doummar,Anne Philippe,Didier Périsse,Claudine Laurent,Nicolas Lebrun,Vincent Guillemot,Jamel Chelly,David Cohen,Delphine Héron,Alexis Brice,Ellen I Closs,Christel Depienne. (2015-07-29) Hypomorphic variants of cationic amino acid transporter 3 in males with autism spectrum disorders.. Amino acids, 47 ((12)): (2647-2658). [PMID:26215737] |
14. N E Paul,R Lösel,K Hemmrich,D Goy,N Pallua,D Klee. (2015-09-26) L-arginine and arginine ethyl ester enhance proliferation of endothelial cells and preadipocytes - how an arginine ethyl ester-releasing biomaterial could support endothelial cell growth in tissue engineering.. Bio-medical materials and engineering, 25 ((3)): (289-297). [PMID:26407115] |
15. Enrique Niza,Matěj Božik,Iván Bravo,Pilar Clemente-Casares,Agustín Lara-Sanchez,Alberto Juan,Pavel Klouček,Carlos Alonso-Moreno. (2020-06-03) PEI-coated PLA nanoparticles to enhance the antimicrobial activity of carvacrol.. Food chemistry, 328 (127131-127131). [PMID:32485586] |
16. Joseph J Dalluge,Jennifer L McCurtain,Adam J Gilbertsen,Kyle A Kalstabakken,Bryan J Williams. (2015-05-11) Determination of agmatine using isotope dilution UPLC-tandem mass spectrometry: application to the characterization of the arginine decarboxylase pathway in Pseudomonas aeruginosa.. Analytical and bioanalytical chemistry, 407 ((18)): (5513-5519). [PMID:25957842] |